Point mutations in genes encoding for H2A and H2B variants were initially identified in uterine [159], bladder and head and neck cancers [160]: R4H, K16T, E57Q in H2A; G27A, E36G, M63K, E76K in H2B. This evidence concerns the gene H2BC21 and head and neck cancer.